U.S. markets close in 58 minutes
Advertisement, Inc. (HEWA)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1800+0.0150 (+9.09%)
As of 12:01PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.1650
Bid3.5000 x 500
Ask4.7500 x 500
Day's Range0.1800 - 0.1800
52 Week Range0.1400 - 0.3000
Avg. Volume33,237
Market Cap9.392M
Beta (5Y Monthly)0.09
PE Ratio (TTM)N/A
EPS (TTM)-0.0220
Earnings DateAug 11, 2022 - Aug 15, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for HEWA

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    Analyst Report: AmerisourceBergen CorporationAmerisourceBergen is a leading pharmaceutical wholesaler engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospital networks, and healthcare providers. Along with McKesson and Cardinal Health, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Through bolt-on acquisitions, the company has expanded into international wholesale in Europe (Alliance Healthcare). AmerisourceBergen provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health).
    Fair Value
    Economic Moat
View more
  • Business Wire Reports Results for First Quarter 2022

    CINCINNATI, May 12,, Inc. (OTC:HEWA) announced today net sales for the first quarter of 2022 totaled $4,314,980, a 13% increase over the same period in 2021, resulting from strong growth in partner services revenue and an increase in direct-to-consumer sales. The Company reported a loss from operations of $213,988 for the quarter while generating positive cash flow of $64,047, as reflected by Adjusted EBITDA (the Company’s non-GAAP internal measure).

  • Business Wire Reports Full Year 2021 Results

    CINCINNATI, March 17,, Inc. said its net sales for 2021 were $16,143,906, with higher prescription sales driven by partner services revenue.

  • Business Wire Reports Results for Third Quarter 2021

    CINCINNATI, November 15,, Inc. (OTCQB: HEWA) announced net sales for the third quarter of 2021 were $4,212,127, a 5% increase from the same quarter in 2020, with prescription sales increasing 13%. The Company reported a loss from operations of $181,031 for its quarter ended September 30, 2021, but positive cash flow, as reflected by its internal non-GAAP measure of Adjusted EBITDA as defined below, which was $89,797 in the third quarter.